The previous research has confirmed that IL-17 and Th17 enhance the proliferation, collagen synthesis and secretion, and migration of SSc patient-derived DVSMCs via the Mitogen-Activated Protein Kinase (MAPKs) signaling pathway.9 This evidence concerns the gene IL17A and systemic sclerosis.